Table 4.
Drug compliance and tolerability.
| Variables | GS-3K8 group (n = 14) | GINST group (n = 15) | Placebo group (n = 15) |
|---|---|---|---|
| Compliance | |||
| Capsules prescribed, mean ± SD | 498.14 ± 6.49 | 499.20 ± 8.13 | 502.80 ± 8.44 |
| Capsule intake, mean ± SD | 456.21 ± 46.36 | 475.73 ± 31.04 | 451.20 ± 47.59 |
| Compliance rate, %, mean ± SD | 91.64 ± 9.80 | 95.28 ± 5.75 | 89.70 ± 8.99 |
| Achieved ≥75% compliance, n (%) | 13 (92.9) | 15 (100) | 15 (100) |
| Tolerability | |||
| Gastrointestinal intolerance, n | 0 | 0 | 0 |
| Taste intolerance, n | 0 | 0 | 0 |
SD, standard deviation.